44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pediatric Health Care and Medicine

Sign up for email alert when new content gets added: Sign up

Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental Glomerulosclerosis in a predominantly pediatric cohort: Time for a reappraisal

3rd International Conference PEDIATRICS & PEDIATRIC HEALTHCARE

April 27-28, 2023 | Amsterdam, The Netherlands

George W Burke

University of Miami, USA

ScientificTracks Abstracts: J Pedia Health Care Med

Abstract :

Background: Primary FSGS manifests with Nephrotic Syndrome and may recur following KT. Failure to respond to conventional therapy after recurrence results in poor outcomes. Evaluation of podocyte B7-1 expression, and treatment with abatacept (a B7-1 antagonist) has shown promise but remains controversial. Methods: From 2012 to 2020, twelve patients developed post-KT FSGS with nephrotic range proteinuria, failed conventional therapy, and were treated with abatacept. Nine/ twelve (< 21 years old) experienced recurrent FSGS; three adults developed de novo FSGS, occurring from immediately, up to eight years after KT. KT biopsies were stained for B7-1. Results: Nine KTRs (75%) responded to abatacept. Seven of nine KTRs were B7-1 positive, and responded with improvement/ resolution of proteinuria. Two patients with rFSGS without biopsies resolved proteinuria after abatacept. Pre-treatment UPCR was 27.0 +/- 20.4 (median 13, range 8-56); follow-up UPCR was 0.8 +/- 1.3 (median 0.2, range 0.07-3.9, P< 0.004). Two patients who were B7-1 negative on multiple KT biopsies did not respond to abatacept, and lost graft function. One patient developed proteinuria while receiving belatacept, stained B7-1 positive, but did not respond to abatacept. Conclusions: Podocyte B7-1 staining in biopsies of KTRs with post-transplant FSGS identifies a subset of patients who may benefit from abatacept. References 1. Sethi S, Glasscock RJ, Fervenza FC (2015) Focal Segmental Glomerulosclerosis: Towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant 30:375–384. 2. D’Agati VD, Kaskel FJ, Falk RJ (2011) Medical progress Focal Segmental Glomerulosclerosis. N Engl J Med 365:2398–2411. 3. Choy BY, Chan TM, Lai KN (2006) Recurrent Glomerulonephritis after kidney transplantation. Am J Transplant 6:2535–2542.

Biography :

George W Burke is currently working as a Professor in the department of Miller School of Medicine, University in Miami Health system, USA. His research interests include Surgery. He is serving as an editorial member and reviewer of several international reputed journals. He is the member of many international affiliations. He has successfully completed his administrative responsibilities. He has authored of many research articles/books related to Surgery.

 
Google Scholar citation report
Citations : 10

Journal of Pediatric Health Care and Medicine received 10 citations as per Google Scholar report

Journal of Pediatric Health Care and Medicine peer review process verified at publons
pulsus-health-tech
Top